2018
DOI: 10.1097/txd.0000000000000837
|View full text |Cite
|
Sign up to set email alerts
|

Abstract: BackgroundTo assess the impact of heart transplantation (HT) on the recovery of peripheral and respiratory muscle mass and strength in patients with congestive heart failure.MethodsThe study included 23 patients with an indication for HT (patients in the waiting list [WL] group). These patients were monitored for 1.5 to 3 years after HT; 8 died before 6 months of follow-up, 15 patients completed the early follow-up period of 6 months after HT (FU6m group), 4 died between 6 months and 3 years after HT, and 11 p… Show more

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
2
2
1

Citation Types

0
7
0

Year Published

2020
2020
2022
2022

Publication Types

Select...
6
1

Relationship

0
7

Authors

Journals

citations
Cited by 7 publications
(7 citation statements)
references
References 25 publications
0
7
0
Order By: Relevance
“…"Definite sarcopenia" is diagnosed when whole-body sarcopenia with low respiratory muscle mass is identified followed by low respiratory muscle strength and/or deteriorated respiratory function with the exclusion of obvious disease causative of low respiratory muscle mass: lung tumors, pulmonary edema, bronchiectasis, diaphragmatic paralysis, neuromuscular diseases, and congenital morphological abnormalities. CT (10,11) and ultrasonography (12)(13)(14) are common methods used to assess respiratory muscle mass. Since, at this point, quantitative measurement of respiratory muscle mass is difficult in clinical settings, it is hard to diagnose a decrease in respiratory muscle mass.…”
Section: Diagnosis Of Respiratory Sarcopeniamentioning
confidence: 99%
See 1 more Smart Citation
“…"Definite sarcopenia" is diagnosed when whole-body sarcopenia with low respiratory muscle mass is identified followed by low respiratory muscle strength and/or deteriorated respiratory function with the exclusion of obvious disease causative of low respiratory muscle mass: lung tumors, pulmonary edema, bronchiectasis, diaphragmatic paralysis, neuromuscular diseases, and congenital morphological abnormalities. CT (10,11) and ultrasonography (12)(13)(14) are common methods used to assess respiratory muscle mass. Since, at this point, quantitative measurement of respiratory muscle mass is difficult in clinical settings, it is hard to diagnose a decrease in respiratory muscle mass.…”
Section: Diagnosis Of Respiratory Sarcopeniamentioning
confidence: 99%
“…Respiratory sarcopenia is caused by various factors such as aging, decreased activity, undernutrition, hypoxic stress, disease, and cachexia (6). Diaphragm and intercostal muscles are the main respiratory muscles (9) and respiratory muscle mass can be measured by computed tomography (CT) (10,11) or ultrasonography (12)(13)(14). Low respiratory muscle strength is commonly evaluated using peak expiratory rate (15) or maximum respiratory pressure (16).…”
Section: Introductionmentioning
confidence: 99%
“…Fernandes et al [48] investigated the impact of HTx on the recovery of peripheral and respiratory muscle mass and strength in patients with congestive HF. They showed significant decreases in a cross-sectional area of the bilateral psoas major muscle (CSAbPm), a bilateral HGS, and the maximum inspiratory and expiratory pressure (MIP and MEP) in patients on the waiting list compared with the healthy controls with normal cardiac function.…”
Section: Impact Of Htx On Sarcopeniamentioning
confidence: 99%
“…However, muscle wasting might be present also in younger patients with HF and non-ischemic dilated cardiomyopathy, particularly in those with advance clinical status[ 48 ]. In literature, some discordant opinions are evident regarding the recovery of skeletal muscle after heart transplantation (HT) or left ventricle assistant device implantation[ 49 ]. Skeletal muscle impairment seems to persist after months from HT and contribute to the impaired exercise capacity[ 50 ], however a recent study demonstrates the recovery of muscle mass and strength after 1.5-3 years of follow up after HT.…”
Section: Sarcopenia In Hfmentioning
confidence: 99%